TwentyTwentyTweets
-
Join 7,195 other subscribers
-
Recent Posts
Pages
Tag Archives: Andrew Lansley
Guest Blogspot: Negotiations with the UK Government over pharmaceutical pricing have achieved a good result for patients, the NHS and the industry.
The UK Government and the pharmaceutical industry shared many objectives throughout the recent drug pricing negotiations. For example, there was always broad agreement that: The total future drug bill needed to be affordable in the context of other spending in … Continue reading
Posted in Andrew Lansley, Business, Cancer, Department of Health, Drugs, Innovation, Jeremy Hunt, NHS, Patients, Pharma, Research, Smoking ban
Tagged 2020health, Andrew Lansley, Department of Health, Drugs, government, innovation, Jeremy Hunt, National Health Service, NHS, NICE, parallel export, parallel imporrt, patient, Patient Access Scheme, Patients, pharmaceutical, PPRS, pricing, R&D, Research, value-based, value-based pricing, VBP
1 Comment
Guest Blogspot: Waiting for Decisions on UK Pharmaceutical Pricing
Little has been heard over how confidential talks between the Government and the pharmaceutical industry are progressing towards the goal of having a new, voluntary UK drug pricing system in place in 2014. In the eyes of the pharmaceutical companies … Continue reading
Posted in Andrew Lansley, Business, Children, Commissioning, David Cameron, Department of Health, Drugs, Emerging technologies, equality, Health and Wellbeing, Innovation, Jeremy Hunt, Uncategorized, Wellbeing
Tagged 2020health, Andrew Lansley, Bowel Cancer UK, Cancer Research UK, Drugs, government, innovation, medicine, Multiple Sclerosis Society, pharmaceutical, R&D, value-based, value-based pricing
1 Comment
Involving patients – informing patients
Contribution to 2020health’s recent report ‘Too posh to wash? Reflections on the future of nursing.’ By Katrina Glaister, Quality Directorate Facilitator, Salisbury NHS Foundation Trust In 2010, in a radical shift in health strategy, the White Paper, ‘Equity and excellence: Liberating … Continue reading
Guest Blogspot: Prevention is better than cure.
The economic consequences of preventing illness are highly complex. Just comparing the costs of prevention with the direct treatment costs that should be avoided is far too simplistic. The true economic impact of preventative measures can often only be assessed … Continue reading
Posted in Alcohol, Business, Children, Elderly, Health Bill, Healthcare, Information, Jeremy Hunt, NHS, Obesity, Patient choice, Patients, Policy, Uncategorized
Tagged accidents, alcohol, Andrew Lansley, arthritis, cancer, cardiovasculsr, cause of dsath, choice, elderly, government, health, Health Bill, injury, Jeremy Hunt, longevity, mortality, National Health Service, NHS, Obesity, Patients, prevention, Public Health, respiratory, smoking, tobacco
Leave a comment
Guest Blogspot: The NHS Constitution- the turning point?
The Health and Social Care Act 2012 has always had my support. All my concerns were addressed in the final Act. The thrust of the Bill remained intact. However, like many other people I was dismayed by the strength of … Continue reading
Posted in Andrew Lansley, Department of Health, Health Bill, Health Team, Healthcare, Hospitals, Innovation, Jeremy Hunt, NHS, Patients, Policy
Tagged 2020health, Andrew Lansley, Constitution, Department of Health, Future Forum, Health and Social Care Act, Health Bill, National Health Service, NHS, NHS complaint, NHS Constitution, NHS Future Forum, patient, Patients, Public Health, traction
Leave a comment
Jeremy Hunt needs to balance diplomacy with determination
2020health comment on the appointment of Jeremy Hunt: 2020health congratulate Jeremy Hunt on his appointment as the new Secretary of State for Health.Gail Beer, Consultant Director at 2020health and former NHS Director commented: “Andrew Lansley got the direction of travel … Continue reading
Guest Blogspot: A wrong decision on UK drug pricing could seriously undermine all the good work that HM Treasury and the Department for Business, Innovation and Skills have done to encourage the UK pharmaceutical industry.
The recent local elections highlight the political dangers ahead. The current UK coalition government has lost popularity through decisions that do not all relate to austerity measures. Shortly after the General Election Andrew Lansley’s plans to increase the say of … Continue reading
Posted in Andrew Lansley, Business, Department of Health, Drugs, Election, Global Health, Health Bill, NHS, Patient choice, Patients, Pharma, Policy, Research, Technology
Tagged 2020health, Andrew Lansley, AstraZeneca, Department of Health, Drugs, GlaxoSmithKline, GSK, health, Health Bill, innovation, medicine, National Health Service, NHS, NICE, patient, Patients, pharmaceutical, PPRS, pricing, R&D, Research, value-based, value-based pricing
Leave a comment
The Health and Social Care Bill: Final Stages in Parliament
With opposition to the Health and Social Care Bill having reached new heights, we must look behind the rhetoric and remember basic principles. The most important point to remember is that the NHS exists to provide the best possible, affordable … Continue reading
Posted in Andrew Lansley, Business, Commissioning, competition, David Cameron, Department of Health, GPs, Health Bill, Hospitals, Inequality, NHS, Patient choice, Patients
Tagged 2020health, Andrew Lansley, Bevan, BMA, bureaucracy, Commissioning, competition, David Cameron, Department of Health, efficiency, government, GP, GPs, health, Health Bill, inaccurate media, National Health Service, NHS, NICE, Nye Bevan, Old age, patient, Patients, Responsibility in healthcare
Leave a comment
Did you brave the ice and snow this weekend?
Adapted from Baby it’s cold outside but don’t slip on the ice until Monday Julia Manning for Daily Mail 3rd Feb With the weather men and women rightly promising us snow last weekend, the advice from the NHS should have … Continue reading
Posted in Uncategorized
Tagged Andrew Lansley, cold, death rate, ice, NHS, snow, UCL, weekend
Leave a comment
2020health's Blog 